Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer.
about
Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with colorectal liver metastases: a Phase II-study and historical comparison with the surgical approach.A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver.Exploratory study of hepatic arterial infusion oxaliplatin with systemic 5-fluorouracil/bevacizumab in patients with refractory solid tumor and extensive liver metastases.Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liver.Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors: a children's oncology group studyA systematic review and meta-analysis to reappraise the role of adjuvant hepatic arterial infusion for colorectal cancer liver metastases.What is the potential role of hepatic arterial infusion chemo-therapy in the current armamentorium against colorectal cancer.The role of aggressive regional therapy for colorectal liver metastases.Postoperative prophylactic hepatic arterial infusion chemotherapy for stage III colorectal cancer: a retrospective study.Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab.The state of regional therapy in the management of metastatic colorectal cancer to the liver.Hepatic arterial infusion of gemcitabine-oxaliplatin in a large metastasis from colon cancer.Hepatic arterial infusion but not systemic application of cetuximab in combination with oxaliplatin significantly reduces growth of CC531 colorectal rat liver metastases.Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies.Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study.Hepatic arterial infusion with oxaliplatin and 5-FU/folinic acid for advanced biliary tract cancer: a phase II study.Pain in Platin-Induced Neuropathies: A Systematic Review and Meta-Analysis.Pharmacokinetics of Irinotecan, Oxaliplatin and 5-Fluorouracil During Hepatic Artery Chronomodulated Infusion: A Translational European OPTILIV Study.
P2860
Q33282669-4EF6A6FC-72CB-4267-BF08-1F7A896C6D96Q33390290-E80298DD-8D2D-446C-A14C-83CB0BED094FQ33393523-76AA9A8F-460B-4707-BF62-635B302AB498Q33422964-B4FBCC2B-CC79-4E29-BC91-58E7784216D8Q33964850-1BE2B9D1-6D73-46E7-AB43-A3DB78B0C9EEQ35640818-63C4A69C-D7F3-4C92-BEAF-0BBD99998C8AQ36097254-0D52C49E-0ECD-4D77-9C8A-B550DCB73081Q36946762-A7E80E98-E42D-4CD9-B6A7-6C89826A5231Q37301343-0EE83361-EF30-47FD-8EB6-F74F48CF0BB0Q38155097-7D6E8208-8CB3-4D87-9E0B-11FE68BD0BD9Q38664762-00D3346D-45B6-4577-954C-A3746CB7104DQ39530243-EFFE18B2-2B66-44A3-9720-F3E4EBAB0DD5Q40219057-55F64DBE-65C8-4FF0-BA86-6FCD89673FADQ40510233-C3ECD1A8-CBAC-4DA3-ADD4-CB68209C0A9EQ42644010-1C08B573-BC2D-48B1-B38F-4780BEE2C561Q42693724-07DE51D8-4F5C-4B5A-9573-C869DF0D39ECQ48192466-650EC251-5F66-4A7D-B535-859FF2EB37DDQ53064537-5C7EB362-BDB9-4644-99B4-D67BEC36DEAC
P2860
Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Phase I and pharmacokinetic st ...... stases from colorectal cancer.
@ast
Phase I and pharmacokinetic st ...... stases from colorectal cancer.
@en
Phase I and pharmacokinetic st ...... stases from colorectal cancer.
@nl
type
label
Phase I and pharmacokinetic st ...... stases from colorectal cancer.
@ast
Phase I and pharmacokinetic st ...... stases from colorectal cancer.
@en
Phase I and pharmacokinetic st ...... stases from colorectal cancer.
@nl
prefLabel
Phase I and pharmacokinetic st ...... stases from colorectal cancer.
@ast
Phase I and pharmacokinetic st ...... stases from colorectal cancer.
@en
Phase I and pharmacokinetic st ...... stases from colorectal cancer.
@nl
P2093
P356
P1433
P1476
Phase I and pharmacokinetic st ...... stases from colorectal cancer.
@en
P2093
A Schalhorn
J Stemmler
M Beykirch
T Waggershauser
W Hiddemann
P304
P356
10.1023/A:1011186708754
P577
2001-05-01T00:00:00Z